Table 4.

Serum lipids and apolipoproteins profile for participants.

Fasting lipid profiles	HC (n = 72)	BPH (n = 74)	PCa (n = 74)	F, p
TC (mmol/L)	4.97 ± 0.91	4.95 ± 0.99	5.38 ± 1.48***	9.06, <0.001
TG (mmol/L)	1.77 ± 1.40	1.87 ± 1.49	1.53 ± 1.02*	2.37, 0.941
HDL-C (mmol/L)	1.42 ± 0.32	1.33 ± 0.26	1.49 ± 0.32*,##	5.49, 0.004
LDL-C (mmol/L)	3.04 ± 0.79	2.99 ± 0.72	3.29 ± 1.27**	4.60, 0.010
Apo-A1 (g/L)	1.48 ± 0.23	1.42 ± 0.22	1.56 ± 0.25**,###	8.54, <0.001
Apo-B (g/L)	1.00 ± 0.24	0.98 ± 0.22	1.04 ± 0.31	1.30, 0.272

HC, healthy control; BPH, benign prostatic hyperplasia; PCa, prostate cancer; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol.

Compared with healthy controls, ^*** p < 0.001, ^** p < 0.01, ^* p < 0.05.

Compared with BPH subjects, ^### p < 0.001, ^## p < 0.01.